Exploring the Evidence: Is Intravenous Ascorbic Acid An Effective and Safe Option For Increasing Hemoglobin Levels In Patients with a Hyporesponse To Epoetin Alfa?

Exploring the Evidence: Is Intravenous Ascorbic Acid An Effective and Safe Option For Increasing Hemoglobin Levels In Patients with a Hyporesponse To Epoetin Alfa?


Identification: nnj_maD4
Issue: March-April 2012
Volume: Vol. 39, No. 2

Standard: $30.00

Author(s)

Credits

Credits: None available.

You must be logged in and own this product in order to post comments.

References